Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135003) titled 'A clinical study of mulberry twig alkaloids tablets for early treatment of adult latent autoimmune diabetes (LADA)' on Oct. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking Union Medical College Hospital
Condition:
latent autoimmune diabetes in adults
Intervention:
SZ-A Treatment Group:Mulberry Twig Alkaloids Tablets
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-11-01
Target Sample Size: SZ-A Treatment Group:34;Placebo Control Group:34;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=34...